Clinical characteristics and mortality in all Czech patients after pacemaker implantation in the last decade

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F23%3A00084464" target="_blank" >RIV/00023001:_____/23:00084464 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216224:14110/23:00133377 RIV/00098892:_____/23:10158253

Výsledek na webu

<a href="https://www.frontiersin.org/articles/10.3389/fcvm.2023.1248145/full" target="_blank" >https://www.frontiersin.org/articles/10.3389/fcvm.2023.1248145/full</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3389/fcvm.2023.1248145" target="_blank" >10.3389/fcvm.2023.1248145</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Clinical characteristics and mortality in all Czech patients after pacemaker implantation in the last decade

Popis výsledku v původním jazyce

Background and aimsAnalysis of mortality from the national health registries and data from a specific central registry dealing with the implantation of pacemakers (REPACE) in Czech patients.Methods and resultsRetrospective observational analysis of pacemakers&apos; implantation in all Czech patients [n = 82,791; 47,070 (56.9%) men, 75.9 +/- 10.4 years old] between 2010 and 2021. Almost 114,000 pacemakers were implanted between 2010 and 2021, of which 27.9% were single-chamber, 67.4% were dual-chamber and 4.6% were biventricular. The annual number of implantations has been steadily increasing with a 6% annual decline in 2020 with increased mortality and reductions in care provided, likely related to COVID-19. The observed 5-year relative survival was 88.6% (overall survival 60.6%) and the 10-year relative survival was 75.9% (overall survival 32.7%). Causes of death 5ary according to the age of the patient. The highest difference 1n the reported numbers in the REPACE Registry did not exceed 2% in comparison with the National Register of Reimbursed Health Services.ConclusionThis study followed all Czech patients with pacemaker&apos;s implantation in between 2010 and 2021. The annual number of 1mplantations has been steadily 1ncreasing. Patients with implanted pacemakers had a significantly higher mortality than the average population. Number of patients in the registry corresponded almost perfectly with the National Register of Reimbursed Health Services.

Název v anglickém jazyce

Clinical characteristics and mortality in all Czech patients after pacemaker implantation in the last decade

Popis výsledku anglicky

Background and aimsAnalysis of mortality from the national health registries and data from a specific central registry dealing with the implantation of pacemakers (REPACE) in Czech patients.Methods and resultsRetrospective observational analysis of pacemakers&apos; implantation in all Czech patients [n = 82,791; 47,070 (56.9%) men, 75.9 +/- 10.4 years old] between 2010 and 2021. Almost 114,000 pacemakers were implanted between 2010 and 2021, of which 27.9% were single-chamber, 67.4% were dual-chamber and 4.6% were biventricular. The annual number of implantations has been steadily increasing with a 6% annual decline in 2020 with increased mortality and reductions in care provided, likely related to COVID-19. The observed 5-year relative survival was 88.6% (overall survival 60.6%) and the 10-year relative survival was 75.9% (overall survival 32.7%). Causes of death 5ary according to the age of the patient. The highest difference 1n the reported numbers in the REPACE Registry did not exceed 2% in comparison with the National Register of Reimbursed Health Services.ConclusionThis study followed all Czech patients with pacemaker&apos;s implantation in between 2010 and 2021. The annual number of 1mplantations has been steadily 1ncreasing. Patients with implanted pacemakers had a significantly higher mortality than the average population. Number of patients in the registry corresponded almost perfectly with the National Register of Reimbursed Health Services.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2023

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Frontiers in cardiovascular medicine

ISSN

2297-055X

e-ISSN

2297-055X

Svazek periodika

10

Číslo periodika v rámci svazku

December 8

Stát vydavatele periodika

CH - Švýcarská konfederace

Počet stran výsledku

10

Strana od-do

"art. no. 1248145"

Kód UT WoS článku

001129381000001

EID výsledku v databázi Scopus

2-s2.0-85180451132